High materiality9/10
Palvella Therapeutics price target lowered to $246 from $270 at H.C. Wainwright
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: $246 target vs current price $138.77; implied upside ~77%; bullish setup.
- Target $246 vs price $138.77; upside ~77%.
Key facts
- 01
Target: $246
- 02
Posted price: $138.77
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.